Deruxtecan, CAS 1599440-13-7

Product Description: Deruxtecan is an ADC drug-linker conjugate composed of an DX-8951 derivative (DXd) and amaleimide-GGFG peptide linker, used for synthesizing DS-8201 and U3-1402.

Applications: Cancer-programmed cell death

Formula: C52H56FN9O13

References: [1]NOGUCHI, Shigeru, et al. METHOD FOR SELECTIVELY MANUFACTURING ANTIBODY-DRUG CONJUGATE. WO2017002776A1./[2]Ogitani Y, et al. Bystander killing effect of DS-8201a, a novel anti-human epidermal growth factor receptor 2 antibody-drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity. Cancer Sci. 2016 Jul;107(7):1039-46.

CAS Number: 1599440-13-7

Molecular Weight: 1034.05

Compound Purity: 99.94

Research Area: Cancer

Solubility: DMSO : 73.33 mg/mL (ultrasonic)

Target: Drug-Linker Conjugates for ADC

• SKU: MEXHY-13631E-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-13631E-1
• Package Unit: 1mg
• Quantity Unit: STK